Trial Profile
A retrospective study of second-line panitumumab monotherapy in patients with metastatic colorectal cancer: Single centre experience
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2015
Price :
$35
*
At a glance
- Drugs Panitumumab (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- 06 Nov 2015 New trial record